IMPORTANCE Low-vision assistive devices are not covered by Medicare and many private insurers, although there is evidence that they can improve functioning and quality of life. Little is known about whether sociodemographic disparities exist in the use of low-vision services by Medicare beneficiaries. RESULTS There were 3058 participants included in the study. The survey weighted proportion of participants who were men was 37.9% (95% CI, 35.8%-40.0%), while 79.1% (95% CI, 77.2%-80.9%) were non-Hispanic white, 10.2% (95% CI, 9.0%-11.5%) were non-Hispanic black, 6.7% (95% CI, 5.6%-8.1%) were Hispanic, and 4.0% (95% CI, 3.2%-5.0%) identified with another race/ethnicity. The weighted proportion who reported using low-vison devices and low-vision rehabilitation were 26.1% (95% CI, 24.2%-28.1%) and 3.5% (95% CI, 2.8%-4.3%), respectively. In a model adjusted for ocular diagnoses, Hispanic individuals (odds ratio, 0.61; 95% CI, 0.39-0.97) and individuals from other races/ethnicities (odds ratio, 0.39; 95% CI, 0.19-0.80), but not black individuals, were significantly less likely to report using low-vision devices than white individuals. In the model that was not adjusted for ocular diagnoses, black individuals (odds ratio, 0.73; 95% CI, 0.54-0.99) were also significantly less likely to report using low-vision devices. There were no significant racial/ethnic disparities for reported use of low-vision rehabilitation.
L ow vision refers to uncorrectable vision impairment (VI).
In 2017, more than 3.8 million adults older than 45 years in the United States were estimated to have low vision, and this number is expected to double by 2050.
1 Impaired vision is associated with decreased quality of life and increased depression, falls, and mortality. 2 Low-vision rehabilitation and assistive devices can improve functioning and quality of life. 2, 3 Vision rehabilitation includes evaluation of activities of daily living and implementation of a therapeutic plan to improve functioning. Components of vision rehabilitation may include mobility training, training in adaptive strategies, and environmental modification, among other interventions. Under current Medicare policy, vision rehabilitation is reimbursable if prescribed by a physician or optometrist and implemented by Medicare providers (eg, physical and occupational therapists).
In contrast, Medicare and many private insurers do not provide coverage for low-vision devices. Current Medicare guidelines are interpreted such that low-vision devices are classified under the same statute as eyeglasses, which are not routinely covered. However, the purpose of low-vision devices, to improve independence in activities of daily living, is identical to that of other assistive equipment that is covered under Medicare for individuals with other disabilities. 4 Prior studies have demonstrated socioeconomic disparities in the use of low-vision devices, 5, 6 although neither study was representative of the US population. In our study, using nationally representative data, we sought to determine whether there are disparities in low-vision device use among older adults with Medicare in the United States, information that may be important in advocating for Medicare coverage of low-vision devices.
Methods

Data Source
The National Health Interview Survey (NHIS) is a crosssectional study used to monitor the health of the US population and has been administered annually through a computerassisted in-person interview since 1997. A vision supplement with questions related to ocular health was included in 2002, 2008, and 2016. Our study sample consisted of adults 65 years or older with Medicare insurance who responded to the vision supplement and answered yes to the question, "Do you have any trouble seeing, even when wearing glasses or contact lenses?" The University of Michigan institutional review board deemed this study exempt because it was a secondary data analysis involving publicly available data.
Variables
Respondents were classified as low-vision device users if they answered yes to the question, "Do you use any adaptive devices such as telescopic or other prescriptive lenses, magnifiers, large print or talking materials, CCTV, white cane, or guide dog?" Respondents were classified as low-vision rehabilitation users if they answered yes to the question, "Do you use any vision rehabilitation services, such as job training, counseling, or training in daily living skills and mobility?"
Statistical Analyses
The 2016 NHIS vision supplement was used to generate nationally representative estimates of low-vision device and rehabilitation use. For all other analyses, household, family, and sample adult files were merged within each year and then combined across the 3 years of the vision supplement (2002, 2008, and 2016) . Since each survey year fell within a different sample design period, we treated each year as statistically independent according to NHIS guidelines. We used the Taylor series linearization method to estimate variance. Based on the complex survey design, we calculated the weighted proportions of participants for each covariate stratified by low-vision device and rehabilitation use. We report unadjusted P values from Pearson χ 2 tests. We performed multivariable logistic regression to examine associations with 2 outcomes: low-vision device and rehabilitation use. We generated 2 sets of models; the first was adjusted for age, sex, race/ethnicity, income relative to the federal poverty level, self-reported ocular comorbidities (cataract, glaucoma, macular degeneration, diabetic retinopathy), and survey year; the second was adjusted for each of the aforementioned covariates except ocular comorbidities. All analyses were conducted using STATA/MP version 15 (StataCorp LP) and accounted for the complex design of NHIS.
Results
This study included 3058 participants. In terms of sociodemographic differences, low-vision device ( Findings In this cross-sectional survey study of a nationally representative sample, older adults in the United States from minority racial/ethnic groups were less likely to report using low-vision devices but not vision rehabilitation compared with white individuals.
Meaning If the associations from this study are confirmed, coverage of low-vision devices by Medicare may help to address a significant health care disparity in the use of this evidence-based intervention.
(AOR, 0.39; 95% CI, 0.19-0.78) ( Table 2 ). There was no significant difference in the likelihood of reporting vision rehabilitation use between racial/ethnic groups. In the model adjusted for all covariates except ocular diagnoses, there were also no racial/ ethnic disparities in rehabilitation use, but black individuals (AOR, 0.73; 95% CI, 0.54-0.99), Hispanic individuals (AOR, 0.53; 95% CI, 0.36-0.78), and individuals of other races/ethnicities (AOR, 0.42; 95% CI, 0.22-0.80) were all less likely to report using low-vision devices (eTable 2 in the Supplement). Reporting use of a low-vision device was not significantly associated with sex, educational attainment, or income as a percent of the federal poverty level in any of our models.
Discussion
We found significant racial/ethnic disparities in the use of lowvision devices but not vision rehabilitation among older adults with Medicare. Since 2002, Medicare has provided coverage of low-vision rehabilitation services but continues not to cover low-vision devices. This is despite evidence from recent clinical trials demonstrating the efficacy of low-vision devices alone and together with vision rehabilitation for improving visiondependent functioning. 3 We presented models both adjusted and unadjusted for selfreported ocular diagnoses. We believe that each of these conveys an important and distinct message. The model adjusted for ocular diagnoses aims to nullify the effect of different eye conditions on patterns of access to low-vision services. Specifically, conditions that tend to cause central vision loss (eg, macular degeneration) are often more amenable to improvement with lowvision devices than those that cause other impairments like peripheral vision loss (eg, glaucoma). 2, 7 However, glaucoma is a highly prevalent eye disease that is more common in black and Hispanic individuals. 8, 9 The model that is unadjusted for ocular diagnoses may unmask meaningful disparities in low-vision treatment options available to minority populations. Respondents who self-reported VI in NHIS likely represent a heterogeneous group with varying levels of VI. However, we do not know whether certain groups who were not candidates for low-vision devices or rehabilitation were more likely to self-report VI. If this was the case, it could have biased our results, with the overreporting group(s) appearing less likely to receive low-vision services. The limited evidence avail- able from prior studies shows that black individuals in the Salisbury Eye Evaluation Study were more likely to selfreport good vision but have poor visual acuity. 10 
Limitations
There were several limitations to our study. Our findings may be limited by recall and social desirability biases, the small number of participants reporting vision rehabilitation, and that we were not able to determine actual need for low-vision devices. While this study supports an association between race/ ethnicity and use of low-vision devices, we cannot determine causation from these data.
Conclusions
In other areas of medicine, expansion of insurance coverage has decreased racial disparities. 11 Additional research is needed to clarify the relationship between sociodemographics and use of low-vision services in the Medicare population. However, if the findings from this study are confirmed, it may suggest that policy makers could consider coverage of low-vision devices under Medicare in an effort to address disparities and expand access to this evidence-based intervention.
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